Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
74.49
+1.23 (1.68%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 183.64 | 94.82 | 224.95 | 71.66 | 171.33 | Upgrade
|
| Short-Term Investments | 233.63 | 196.56 | 2.5 | 145.37 | 0.48 | Upgrade
|
| Cash & Short-Term Investments | 417.27 | 291.38 | 227.44 | 217.03 | 171.82 | Upgrade
|
| Cash Growth | 43.21% | 28.11% | 4.80% | 26.31% | 2.19% | Upgrade
|
| Accounts Receivable | 85.06 | 46.76 | 16.62 | - | - | Upgrade
|
| Other Receivables | 2.05 | 1.3 | 1.09 | 3.58 | 0.09 | Upgrade
|
| Receivables | 87.11 | 48.06 | 17.71 | 3.58 | 0.09 | Upgrade
|
| Inventory | 4.37 | 2.62 | 3.11 | - | - | Upgrade
|
| Prepaid Expenses | 13.47 | 14.65 | 7.87 | 4.77 | 4.05 | Upgrade
|
| Restricted Cash | 0.56 | - | - | - | - | Upgrade
|
| Total Current Assets | 522.78 | 356.71 | 256.13 | 225.38 | 175.95 | Upgrade
|
| Property, Plant & Equipment | 21.75 | 2.87 | 3.35 | 1.53 | 1.83 | Upgrade
|
| Long-Term Investments | 3.87 | 3 | 0.86 | 0.48 | 0.66 | Upgrade
|
| Other Intangible Assets | 7.37 | 8.33 | 3.87 | - | - | Upgrade
|
| Other Long-Term Assets | 6.4 | 6.09 | 1.29 | 0.48 | 0.46 | Upgrade
|
| Total Assets | 562.16 | 376.99 | 265.49 | 227.86 | 178.91 | Upgrade
|
| Accounts Payable | 16.39 | 9.42 | 17.77 | 5.5 | 2.86 | Upgrade
|
| Accrued Expenses | 26.88 | 19.14 | 13.9 | 9.21 | 7.26 | Upgrade
|
| Current Portion of Leases | - | 0.61 | 0.4 | 0.72 | 0.61 | Upgrade
|
| Current Income Taxes Payable | 1.81 | - | - | - | 0.06 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.7 | Upgrade
|
| Other Current Liabilities | 90.62 | 51.44 | 4.87 | - | - | Upgrade
|
| Total Current Liabilities | 135.7 | 80.61 | 36.94 | 15.43 | 11.48 | Upgrade
|
| Long-Term Debt | 72.44 | 71.85 | 29.82 | 19.43 | - | Upgrade
|
| Long-Term Leases | 10.6 | - | - | - | 0.59 | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.75 | 0.1 | 0.11 | Upgrade
|
| Total Liabilities | 218.73 | 152.46 | 68.5 | 34.96 | 12.18 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 769.67 | 584.56 | 441.64 | 301.73 | 213.4 | Upgrade
|
| Retained Earnings | -426.63 | -360.21 | -244.66 | -108.76 | -46.67 | Upgrade
|
| Comprehensive Income & Other | 0.38 | 0.18 | -0 | -0.07 | - | Upgrade
|
| Total Common Equity | 343.43 | 224.53 | 196.99 | 192.9 | 166.73 | Upgrade
|
| Shareholders' Equity | 343.43 | 224.53 | 196.99 | 192.9 | 166.73 | Upgrade
|
| Total Liabilities & Equity | 562.16 | 376.99 | 265.49 | 227.86 | 178.91 | Upgrade
|
| Total Debt | 83.04 | 72.45 | 30.22 | 20.16 | 1.19 | Upgrade
|
| Net Cash (Debt) | 334.23 | 218.92 | 197.23 | 196.87 | 170.62 | Upgrade
|
| Net Cash Growth | 52.67% | 11.00% | 0.18% | 15.38% | 1.99% | Upgrade
|
| Net Cash Per Share | 8.00 | 5.82 | 6.71 | 8.00 | 8.30 | Upgrade
|
| Filing Date Shares Outstanding | 42.56 | 38.38 | 34.22 | 26.73 | 20.71 | Upgrade
|
| Total Common Shares Outstanding | 42.55 | 38.35 | 34.21 | 26.73 | 20.7 | Upgrade
|
| Working Capital | 387.09 | 276.09 | 219.2 | 209.95 | 164.47 | Upgrade
|
| Book Value Per Share | 8.07 | 5.85 | 5.76 | 7.22 | 8.06 | Upgrade
|
| Tangible Book Value | 336.06 | 216.21 | 193.12 | 192.9 | 166.73 | Upgrade
|
| Tangible Book Value Per Share | 7.90 | 5.64 | 5.64 | 7.22 | 8.06 | Upgrade
|
| Machinery | 3.84 | 3.5 | 2.08 | 1.08 | 0.85 | Upgrade
|
| Leasehold Improvements | 9.93 | 0.79 | 0.68 | 0.43 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.